ENTA
Enanta Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.08
+0.43%Margins
Gross margin
98.1%
EBITDA margin
-71.2%
EBIT margin
-90.0%
Net margin
-96.9%
FCF margin
-56.6%
-62.6%
Return on equity
-21.3%
Return on assets
-37.5%
Return on invested capital
0.21x
Asset turnover
-$35.3M
Cash from operations
$6.51
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026